American Century Companies Inc. Lowers Position in Ingredion Incorporated $INGR

American Century Companies Inc. cut its stake in shares of Ingredion Incorporated (NYSE:INGR) by 12.4% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 283,062 shares of the company’s stock after selling 39,933 shares during the period. American Century Companies Inc. owned about 0.45% of Ingredion worth $34,565,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of the company. Norges Bank purchased a new stake in Ingredion during the second quarter worth about $82,779,000. Boston Trust Walden Corp boosted its stake in Ingredion by 6,843.0% in the third quarter. Boston Trust Walden Corp now owns 136,915 shares of the company’s stock valued at $16,719,000 after acquiring an additional 134,943 shares during the last quarter. Cooke & Bieler LP grew its position in shares of Ingredion by 16.0% during the 3rd quarter. Cooke & Bieler LP now owns 903,346 shares of the company’s stock valued at $110,308,000 after acquiring an additional 124,517 shares during the period. Massachusetts Financial Services Co. MA grew its position in shares of Ingredion by 10.0% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 1,340,015 shares of the company’s stock valued at $181,733,000 after acquiring an additional 121,387 shares during the period. Finally, Treasurer of the State of North Carolina increased its stake in shares of Ingredion by 139.5% during the 2nd quarter. Treasurer of the State of North Carolina now owns 203,957 shares of the company’s stock worth $27,661,000 after purchasing an additional 118,812 shares during the last quarter. 85.27% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Ingredion

In related news, CEO James P. Zallie sold 33,597 shares of the stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $119.66, for a total value of $4,020,217.02. Following the sale, the chief executive officer owned 50,167 shares in the company, valued at approximately $6,002,983.22. This trade represents a 40.11% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, SVP Larry Fernandes sold 3,630 shares of Ingredion stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $118.40, for a total value of $429,792.00. Following the sale, the senior vice president directly owned 32,055 shares of the company’s stock, valued at $3,795,312. This represents a 10.17% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 48,310 shares of company stock valued at $5,741,733. Insiders own 2.30% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts recently commented on the company. Barclays upped their price objective on Ingredion from $124.00 to $128.00 and gave the company an “equal weight” rating in a research note on Wednesday, February 4th. Weiss Ratings restated a “hold (c)” rating on shares of Ingredion in a research note on Monday, December 29th. Wall Street Zen downgraded Ingredion from a “buy” rating to a “hold” rating in a research note on Saturday, January 31st. Jefferies Financial Group reissued a “hold” rating on shares of Ingredion in a report on Wednesday, February 4th. Finally, Stephens restated an “equal weight” rating and issued a $120.00 price objective on shares of Ingredion in a research note on Wednesday, February 4th. One research analyst has rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat, Ingredion has a consensus rating of “Hold” and a consensus target price of $125.83.

Ingredion Stock Up 2.0%

INGR stock opened at $115.06 on Friday. The stock has a 50-day simple moving average of $115.65 and a two-hundred day simple moving average of $116.52. Ingredion Incorporated has a twelve month low of $102.31 and a twelve month high of $141.78. The firm has a market capitalization of $7.24 billion, a PE ratio of 10.31, a PEG ratio of 0.91 and a beta of 0.69. The company has a quick ratio of 1.73, a current ratio of 2.66 and a debt-to-equity ratio of 0.41.

Ingredion (NYSE:INGR) last announced its quarterly earnings results on Tuesday, February 3rd. The company reported $2.53 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.59 by ($0.06). The firm had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.78 billion. Ingredion had a return on equity of 17.32% and a net margin of 10.10%.The company’s quarterly revenue was down 2.4% compared to the same quarter last year. During the same period in the previous year, the company posted $2.63 earnings per share. Ingredion has set its FY 2026 guidance at 11.000-11.8 EPS. On average, equities analysts predict that Ingredion Incorporated will post 11.14 EPS for the current fiscal year.

Ingredion Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, January 20th. Shareholders of record on Friday, January 2nd were issued a $0.82 dividend. This represents a $3.28 annualized dividend and a yield of 2.9%. The ex-dividend date of this dividend was Friday, January 2nd. Ingredion’s dividend payout ratio (DPR) is presently 29.39%.

About Ingredion

Ingredion Incorporated is a global ingredient solutions company specializing in the production and sale of starches, sweeteners, nutrition ingredients and biomaterials derived primarily from corn and other plant-based raw materials. The company serves a diverse set of industries, including food and beverage, brewing, pharmaceuticals and personal care, providing functional ingredients that enhance texture, stability, flavor and nutritional value in a wide array of end products.

The company’s product portfolio comprises native and modified starches, high-fructose corn syrup, dextrose, maltodextrins, specialty sweeteners and various texturizers.